Carey Robert
Insider CIK 1602064 · SGMO Director · ARGS Director · HZNP EVP, Chief Business Officer · AITB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-07 | 50 | — | $0 | 50 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-07 | 50 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-07 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-07 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-07 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-07 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-07 | 1,500 | — | $0 | 1,500 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-07 | 1,500 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-07 | 2,000 | — | $0 | 2,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-07 | 2,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-07 | 4,500 | — | $0 | 4,500 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-07 | 4,500 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-07 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-07 | 10,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-07 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-03 | 2025-11-07 | 494,332 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | J Other deriv | 2025-11-03 | 2025-11-07 | 512,821 | — | $0 | 512,821 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-03 | 2025-11-07 | 494,332 | — | $0 | 494,332 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2025-06-12 | 2025-06-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2025-06-12 | 2025-06-16 | 25,000 | — | $0 | 99,600 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-03-26 | 2025-03-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2025-03-14 | 2025-03-17 | 10,000 | $0.26 | $2.6K | 4,076,864 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2025-03-14 | 2025-03-17 | 990,000 | $0.25 | $247.5K | 4,066,864 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 1,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 30,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 40,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 90,000 | — | $0 | 90,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 90,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 1,000 | — | $0 | 1,000 | SEC↗ |
| XAIR Beyond Air, Inc. | J Other deriv | 2024-09-27 | 2024-10-01 | 9,886,633 | — | $0 | 9,886,633 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy deriv | 2024-09-26 | 2024-10-01 | 26,142 | — | $0 | 26,142 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy deriv | 2024-09-26 | 2024-10-01 | 1,880,565 | — | $0 | 1,880,565 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy deriv | 2024-09-26 | 2024-10-01 | 102,382 | — | $0 | 102,382 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy deriv | 2024-09-26 | 2024-10-01 | 480,179 | — | $0 | 480,179 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2024-09-26 | 2024-10-01 | 1,476,626 | $0.50 | $738.3K | 1,476,626 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2024-08-14 | 2024-08-15 | 100,000 | $0.40 | $40.0K | 3,076,864 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2024-06-04 | 2024-06-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2024-06-04 | 2024-06-06 | 25,000 | — | $0 | 74,600 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-03-20 | 2024-03-21 | 602,410 | — | $0 | 602,410 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-03-20 | 2024-03-21 | 90,000 | — | $0 | 90,000 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award | 2024-03-20 | 2024-03-21 | 602,410 | $1.66 | $1.00M | 2,976,864 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-12-18 | 2023-12-19 | 1,200,000 | $1.64 | $1.97M | 2,374,454 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-08-28 | 2023-08-29 | 250,000 | $2.70 | $675.0K | 1,225,160 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-08-21 | 2023-08-22 | 75,050 | $2.76 | $207.1K | 975,160 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-08-18 | 2023-08-22 | 13,614 | $2.64 | $35.9K | 900,110 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2023-06-01 | 2023-06-05 | 27,750 | — | $0 | 27,750 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2023-06-01 | 2023-06-05 | 13,900 | — | $0 | 49,600 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-30 | 2023-03-30 | 10,000 | $6.45 | $64.5K | 886,496 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-29 | 2023-03-30 | 10,000 | $6.30 | $63.0K | 876,496 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-14 | 2023-03-15 | 10,000 | $6.85 | $68.5K | 866,496 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-13 | 2023-03-15 | 4,173 | $6.15 | $25.7K | 856,496 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-08 | 2023-03-09 | 10,000 | $5.95 | $59.5K | 852,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-12-07 | 2022-12-09 | 20,000 | $5.75 | $115.0K | 842,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-11-29 | 2022-11-30 | 15,000 | $5.75 | $86.3K | 822,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-11-28 | 2022-11-30 | 15,000 | $5.75 | $86.3K | 807,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-11-18 | 2022-11-18 | 20,000 | $5.80 | $116.0K | 792,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-11-17 | 2022-11-18 | 20,000 | $5.90 | $118.0K | 772,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-11-16 | 2022-11-18 | 10,000 | $6.00 | $60.0K | 752,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-06-30 | 2022-07-05 | 175,000 | $6.45 | $1.13M | 742,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-04-05 | 2022-04-06 | 20,000 | $6.71 | $134.2K | 567,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-03-25 | 2022-03-28 | 22,500 | $6.65 | $149.6K | 547,323 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-03-24 | 2022-03-28 | 3,685 | $6.58 | $24.2K | 524,823 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2022-03-17 | 2022-03-21 | 20,000 | $6.75 | $135.0K | 521,138 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2022-03-03 | 2022-03-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2022-02-25 | 2022-03-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2022-02-25 | 2022-03-01 | 12,500 | — | $0 | 35,700 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2021-12-22 | 2021-12-27 | 10,000 | $9.50 | $95.0K | 518,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2021-11-23 | 2021-11-26 | 5,000 | $12.35 | $61.8K | 508,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2021-11-22 | 2021-11-24 | 10,000 | $12.05 | $120.5K | 503,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2021-11-19 | 2021-11-23 | 12,000 | $14.10 | $169.2K | 493,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2021-06-17 | 2021-06-21 | 350,000 | $5.36 | $1.88M | 481,418 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2021-03-04 | 2021-03-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2021-03-04 | 2021-03-05 | 17,000 | $5.70 | $96.9K | 131,418 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2021-02-25 | 2021-03-01 | 16,400 | — | $0 | 16,400 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2021-02-25 | 2021-03-01 | 8,200 | — | $0 | 23,200 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2021-02-18 | 2021-02-18 | 15,000 | $6.67 | $100.0K | 114,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2020-08-24 | 2020-08-26 | 10,000 | $5.70 | $57.0K | 99,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2020-08-14 | 2020-08-18 | 10,000 | $5.50 | $55.0K | 39,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2020-08-14 | 2020-08-18 | 50,000 | $5.65 | $282.5K | 89,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2020-08-13 | 2020-08-17 | 5,000 | $5.30 | $26.5K | 29,418 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2020-08-13 | 2020-08-17 | 5,000 | $5.45 | $27.3K | 24,418 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-05-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-05-20 | 2,500 | — | $0 | 7,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-06-03 | 10,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2019-06-10 | 2019-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2019-06-10 | 2019-06-12 | 2,500 | — | $0 | 5,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2019-06-03 | 2019-11-22 | 19,418 | $5.15 | $100.0K | 19,418 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2019-03-23 | 2019-03-25 | 31,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2019-03-23 | 2019-03-25 | 31,000 | — | $0 | 31,000 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2019-03-23 | 2019-03-25 | 13,733 | $26.84 | $368.6K | 17,267 | SEC↗ |
| HZNP Horizon Pharma plc | A Award | 2019-02-20 | 2019-02-22 | 72,375 | — | $0 | 72,375 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2019-02-20 | 2019-02-22 | 32,064 | $21.54 | $690.7K | 40,311 | SEC↗ |
| AITB AIT Therapeutics, Inc. | A Award deriv | 2019-02-13 | 2019-02-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2019-01-05 | 2019-01-08 | 65,695 | — | $0 | 131,392 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2019-01-05 | 2019-01-08 | 65,695 | — | $0 | 65,695 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2019-01-05 | 2019-01-08 | 29,419 | $20.39 | $599.9K | 36,276 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2019-01-04 | 2019-01-08 | 53,948 | — | $0 | 53,948 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2018-06-11 | 2018-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2018-06-11 | 2018-06-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2018-05-03 | 2018-05-07 | 197,087 | — | $0 | 197,087 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2018-03-23 | 2018-03-27 | 31,000 | — | $0 | 31,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2018-03-23 | 2018-03-27 | 31,000 | — | $0 | 48,189 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2018-03-23 | 2018-03-27 | 9,083 | $13.86 | $125.9K | 39,106 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2018-03-05 | 2018-03-07 | 31,025 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2018-03-05 | 2018-03-07 | 13,836 | $15.83 | $219.0K | 17,189 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2018-03-05 | 2018-03-07 | 31,025 | — | $0 | 31,025 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2017-06-05 | 2017-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-03-23 | 2017-03-24 | 31,000 | — | $0 | 62,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2017-03-23 | 2017-03-24 | 31,000 | — | $0 | 48,357 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2017-03-23 | 2017-03-24 | 14,167 | $14.56 | $206.3K | 34,190 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-03-05 | 2017-03-07 | 31,025 | — | $0 | 31,025 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2017-03-05 | 2017-03-07 | 14,268 | $16.11 | $229.9K | 17,357 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2017-03-05 | 2017-03-07 | 31,025 | — | $0 | 31,625 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2017-03-01 | 2017-03-02 | 30,000 | $16.00 | $480.0K | 95,408 | SEC↗ |
| HZNP Horizon Pharma plc | X Exercise deriv | 2017-02-28 | 2017-03-02 | 6,913 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | X Exercise | 2017-02-28 | 2017-03-02 | 6,913 | $4.31 | $29.8K | 127,216 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2017-02-28 | 2017-03-02 | 1,808 | $16.48 | $29.8K | 125,408 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | A Award deriv | 2017-01-19 | 2017-01-20 | 9,500 | — | $0 | 9,500 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | A Award | 2016-12-31 | 2017-01-04 | 2,351 | — | $0 | 8,206 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | A Award | 2016-09-30 | 2016-10-03 | 2,263 | — | $0 | 5,855 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | A Award | 2016-06-30 | 2016-07-05 | 1,835 | — | $0 | 3,592 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2016-06-14 | 2016-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | A Award deriv | 2016-06-13 | 2016-06-14 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ARGS ARGOS THERAPEUTICS INC | A Award | 2016-03-31 | 2016-04-04 | 1,757 | — | $0 | 1,757 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2016-03-23 | 2016-03-24 | 31,000 | — | $0 | 93,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2016-03-23 | 2016-03-24 | 31,000 | — | $0 | 52,409 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2016-03-23 | 2016-03-24 | 14,167 | $16.32 | $231.2K | 38,242 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2016-03-05 | 2016-03-07 | 31,025 | — | $0 | 62,050 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2016-03-05 | 2016-03-07 | 31,025 | — | $0 | 31,025 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2016-03-05 | 2016-03-07 | 9,616 | $16.78 | $161.4K | 21,409 | SEC↗ |
| HZNP Horizon Pharma plc | G Gift | 2016-02-19 | 2016-03-07 | 24,406 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | G Gift | 2016-02-19 | 2016-03-07 | 24,406 | — | $0 | 82,061 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-05-06 | 2015-05-08 | 699,000 | — | $0 | 699,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-03-23 | 2015-03-25 | 124,000 | — | $0 | 124,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-03-23 | 2015-03-25 | 233,000 | — | $0 | 233,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-03-23 | 2015-03-25 | 276,000 | — | $0 | 276,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2015-03-05 | 2015-03-09 | 31,025 | — | $0 | 93,075 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2015-03-05 | 2015-03-09 | 31,025 | — | $0 | 32,981 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 9,736 | $20.84 | $202.9K | 23,245 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 124,100 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 140,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 100,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 6,913 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 6,913 | — | $0 | 6,913 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 124,100 | — | $0 | 124,100 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 140,000 | — | $0 | 140,000 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer | 2014-09-19 | 2014-09-22 | 57,655 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award | 2014-09-19 | 2014-09-22 | 57,655 | — | $0 | 57,655 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-03-05 | 2014-03-07 | 140,000 | — | $0 | 140,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-03-05 | 2014-03-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-03-05 | 2014-03-07 | 124,100 | — | $0 | 124,100 | SEC↗ |